iRobot Corp. (NASDAQ: IRBT), a leader in delivering robotic technology-based solutions, today announced a $6 million investment and expanded partnership with InTouch Health, a leading remote presence telemedicine solution provider. The $6 million investment represents a minority position in the company.
Today's announcement expands upon the joint development and licensing agreement iRobot announced in July 2011, which was established to explore opportunities for healthcare applications on iRobot platforms, such as the iRobot Ava mobile robotics platform. Under the expanded agreement, InTouch Health will provide access to FDA regulated healthcare facilities, providing iRobot with an initial foray into hospitals, emergency care facilities, patient wards and operating and procedure rooms. Working closely together, iRobot and InTouch will collaborate on a wide variety of technologies across each company's patent portfolio and leverage combined expertise in remote presence telemedicine solutions.
"Currently operating in over eighty hospitals in the U.S. and around the world, InTouch is in a very unique position as one of the first developers of FDA-cleared telemedicine devices," said Colin Angle, chairman and CEO of iRobot. "iRobot's investment will further align these two leaders, creating a best of breed partnership that will develop robots for remote healthcare and assistive technologies for the elderly."
"As evident from the demonstrations of Ava, iRobot is the industry leader in navigation, mobility, manipulation and artificial intelligence." said Yulun Wang, chairman and CEO of InTouch Health. "Working together, InTouch Health and iRobot will pioneer remote presence in healthcare settings, providing anytime anywhere patient care in hospital ICU's, patient wards and operating and procedure rooms."
Breaking through new research barriers with iPSC technology